[Class : 3] Cosmetics , Aromatic Essential Oils, Aftershave,,Washing Soap And Powder , Bath Powders For Cosmetic Purposes,Bath Lotion, Baby Body Milk, Bath Soap, Body And Beauty Carecosmetics, Body Cleaning And Beauty Care Preparations, Bodydeodorants, Body Gels, Powder, Cleaning Preparations, Cleansingmilk, Colognes,Coloring Preparations For Cosmetic Purposes,Cosmetic And B...
[Class : 5] Medicinal Preparations And Pharmaceutical Preparations
View +25 more Brands for Kimirica Lifestyle Private Limited.
Documents
Form ADT-1-31122022_signed
Form AOC-4-31122022_signed
Form MGT-7A-31122022_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-26122022
Copy of resolution passed by the company-26122022
Copy of written consent given by auditor-26122022
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-26122022
Directors report as per section 134(3)-26122022
List of Directors;-26122022
List of share holders, debenture holders;-26122022
Optional Attachment-(1)-26122022
Form DIR-12-12042022_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-08042022
Optional Attachment-(2)-08042022
Optional Attachment-(1)-08042022
Form MGT-14-25032022-signed
Optional Attachment-(3)-09032022
Optional Attachment-(2)-09032022
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-09032022
Optional Attachment-(1)-09032022
Form PAS-3-27022022_signed
Complete record of private placement offers and acceptances in Form PAS-5.-27022022
Copy of Board or Shareholders? resolution-27022022
Optional Attachment-(1)-27022022
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-27022022
Form INC-20A-10022022_signed
Optional Attachment-(1)-10022022
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-10022022